INTERLEUKIN-18 LEVELS IN SCHIZOPHRENIA PATIENTS RECEIVING ANTI-PSYCHOTIC THERAPY AT THE PSYCHIATRIC POLYCLINIC OF SITI RAHMAH ISLAMIC HOSPITAL
The use of antipsychotic therapy is effective in managing symptoms and has become a cornerstone in the treatment of patients with schizophrenia. However, antipsychotics have side effects on the immune system, particularly affecting Interleukin 18 (IL-18) levels. Therefore, it is important to assess...
Saved in:
| Main Authors: | Dita Hasni, Debie Anggraini, Mutiara Anissa |
|---|---|
| Format: | Article |
| Language: | Indonesian |
| Published: |
Universitas Sriwijaya
2025-01-01
|
| Series: | Jurnal Kedokteran dan Kesehatan |
| Subjects: | |
| Online Access: | https://jkk-fk.ejournal.unsri.ac.id/index.php/jkk/article/view/475 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of factors associated with obesity in patients using antipsychotics in schizophrenia
by: Vishalakshi Patnam, et al.
Published: (2024-12-01) -
Pharmacotherapy of Psychotic Disorders in Türkiye: Insights From a National Prescription Database
by: Sena Türkeş, et al.
Published: (2025-07-01) -
The treatment characteristics of oral antipsychotics in treatment of adolescents with schizophrenia in China
by: Huaning Wang, et al.
Published: (2025-07-01) -
Pattern of Antipsychotics in Schizophrenia Outpatients at Lampung Province Mental Hospital
by: Isnenia Isnenia
Published: (2022-03-01) -
Sexual differences in the clinical features of antipsychotic-induced hyperprolactinemia in patients with schizophrenia
by: E. G. Kornetova, et al.
Published: (2019-10-01)